QA Financial Forum London | 11 September 2024 | BOOK TICKETS
Search
Close this search box.

Antithesis gets $47m capital injection to expand testing tools and go to market

Will Wilson, co-founder and CEO of Antithesis
Will Wilson, co-founder and CEO of Antithesis

Antithesis has raised $47 million in fresh funding to give its software testing platform a capital injection.

The funds will also be used to further develop its debugging tool and speed up the firm’s go-to-market strategy, the company stated. So far, the company's tools have not been released ye...

To view this content please sign in below or register here for free, immediate access.